Fig. 4
From: Microbiological profile of patients treated for postoperative peritonitis: temporal trends 1999–2019
Theoretical adequacy rates of EAT expressed in proportions with various regimens for patients with/without MDRO during the 1999–2019 period. *p < 0.0001; †p < 0.01; °p < 0.05 versus MDROs with the same regimen. Footnote AMK: amikacin; CIP: ciprofloxacin; GEN: gentamicin; IMI: imipenem/cilastatin; MET: metronidazole; TZP: piperacillin/tazobactam; VAN: vancomycin